Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

    20 August 2022

    • curprev 04:2604:26, 20 August 2022‎ 187.21.138.9 talk‎ 491 bytes +491‎ Created page with "== Target Article == Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action; FM Yakes, W Chinratanalab, CA itter, W Kingae; 2002; doi_citing_unknown == Retraction == The HER-2/neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy ; Jeffrey S Ross Jonathan A Fletcher; 08/01/1998 ; doi_cited_unknown == Citation piece == Note: Open to app..."
Retrieved from "https://wikicitingretracted.org/index.php?title=Herceptin-induced_inhibition_of_phosphatidylinositol-3_kinase_and_Akt_Is_required_for_antibody-mediated_effects_on_p27,_cyclin_D1,_and_antitumor_action"